Haleon (HLN) Short-term Investments (2021 - 2025)
Haleon (HLN) posted Short-term Investments of $103.8 million for Q4 2025, down 37.82% on a QoQ basis from $166.9 million in Q4 2024, and down 37.82% year-over-year from $166.9 million in Q4 2024.
Haleon (HLN) Short-term Investments (2021 - 2025) Analysis & Trends
Haleon's Short-term Investments history runs 5 years deep, the most recent figure standing at $103.8 million for Q4 2025.
- Quarterly Short-term Investments fell 37.82% year-over-year to $103.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $103.8 million (down 37.82% YoY) and the FY2025 annual result came in at $102.8 million, down 38.11% from the prior year.
- Short-term Investments was $103.8 million for Q4 2025 at Haleon, down from $166.9 million in the prior quarter.
- Across five years, Short-term Investments topped out at $183.9 million in Q2 2022 and bottomed at -$231.5 million in Q2 2023.
- A 5-year average of $23.5 million and a median of $43.6 million in 2022 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments surged 770.12% — and 2023, when it plunged 225.91%.
- Haleon's Short-term Investments stood at $6.7 million in 2021, then jumped by 770.12% to $58.6 million in 2022, then tumbled by 51.32% to $28.5 million in 2023, then jumped by 484.5% to $166.9 million in 2024, then tumbled by 37.82% to $103.8 million in 2025.
- Business Quant data shows HLN's Short-term Investments at $103.8 million in Q4 2025, $166.9 million in Q4 2024, and -$128.7 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103.75 Mn |
| Dec 31, 2024 | 166.86 Mn |
| Jun 30, 2024 | -128.75 Mn |
| Dec 31, 2023 | 28.55 Mn |
| Jun 30, 2023 | -231.50 Mn |
| Dec 31, 2022 | 58.65 Mn |
| Jun 30, 2022 | 183.86 Mn |
| Dec 31, 2021 | 6.74 Mn |